Træk
Nausea and vomiting
Nausea is a commonly encountered symptom that has been defined as an unpleasant painless subjective feeling that one will imminently vomit. Vomiting has been defined as the forceful expulsion of the contents of the stomach, duodenum, or jejunum through the oral cavity. While nausea and vomiting are often thought to exist on a temporal continuum, this is not always the case. There are situations when severe nausea may be present without emesis and less frequently, when emesis may be present without preceding nausea.
Resumé
- Kropssystem
- Abnormality of the digestive system
ReferencegenomGRCh38hg38
Positioner på gen- og variantsider følger dette valg i denne browser.
Read the genes linked to Nausea and vomiting, and the rest of your genome, with one test.
Fra 449 $Gratis forsendelse · Resultater på 6–8 uger
Bestil min Genome Test153 gener knyttet til Nausea and vomiting
Ændringer i disse gener forårsager sjældne tilstande, hvor Nausea and vomiting ses. De fleste med dette træk har ingen af disse tilstande, og et gen på denne liste siger intet om nogens eget genom.
| Gen | Hvor ofte det ses | Tilstande |
|---|---|---|
| ATP9AATPase phospholipid transporting 9A | Altid | I 1 tilstand |
| NOTCH3notch receptor 3 | Altid | I 1 tilstand |
| SLC25A4solute carrier family 25 member 4 | Altid | I 1 tilstand |
| ABCD1ATP binding cassette subfamily D member 1 | Meget ofte (80–99 %) | I 1 tilstand |
| ACTG2actin gamma 2, smooth muscle | Meget ofte (80–99 %) | I 1 tilstand |
| ATP7AATPase copper transporting alpha | Meget ofte (80–99 %) | I 2 tilstande |
| BCL10BCL10 immune signaling adaptor | Meget ofte (80–99 %) | I 1 tilstand |
| BIRC3baculoviral IAP repeat containing 3 | Meget ofte (80–99 %) | I 1 tilstand |
| BRCA1BRCA1 DNA repair associated | Meget ofte (80–99 %) | I 2 tilstande |
| C4Acomplement C4A (Chido/Rodgers blood group) | Meget ofte (80–99 %) | I 1 tilstand |
| CCR1C-C motif chemokine receptor 1 | Meget ofte (80–99 %) | I 1 tilstand |
| ECE1endothelin converting enzyme 1 | Meget ofte (80–99 %) | I 1 tilstand |
| EDN3endothelin 3 | Meget ofte (80–99 %) | I 1 tilstand |
| EDNRBendothelin receptor type B | Meget ofte (80–99 %) | I 1 tilstand |
| ERAP1endoplasmic reticulum aminopeptidase 1 | Meget ofte (80–99 %) | I 1 tilstand |
| ERBB2erb-b2 receptor tyrosine kinase 2 | Meget ofte (80–99 %) | I 2 tilstande |
| ERBB3erb-b2 receptor tyrosine kinase 3 | Meget ofte (80–99 %) | I 1 tilstand |
| FASFas cell surface death receptor | Meget ofte (80–99 %) | I 1 tilstand |
| FOXP1forkhead box P1 | Meget ofte (80–99 %) | I 1 tilstand |
| FSHRfollicle stimulating hormone receptor | Meget ofte (80–99 %) | I 1 tilstand |
| GDNFglial cell derived neurotrophic factor | Meget ofte (80–99 %) | I 1 tilstand |
| HLA-Bmajor histocompatibility complex, class I, B | Meget ofte (80–99 %) | I 2 tilstande |
| HLCSholocarboxylase synthetase | Meget ofte (80–99 %) | I 1 tilstand |
| IFNGR1interferon gamma receptor 1 | Meget ofte (80–99 %) | I 1 tilstand |
| IGHimmunoglobulin heavy locus | Meget ofte (80–99 %) | I 1 tilstand |
| IKZF1IKAROS family zinc finger 1 | Meget ofte (80–99 %) | I 1 tilstand |
| IL10interleukin 10 | Meget ofte (80–99 %) | I 1 tilstand |
| IL12Ainterleukin 12A | Meget ofte (80–99 %) | I 1 tilstand |
| IL12A-AS1IL12A antisense RNA 1 | Meget ofte (80–99 %) | I 1 tilstand |
| IL23Rinterleukin 23 receptor | Meget ofte (80–99 %) | I 1 tilstand |
| ITGA6integrin subunit alpha 6 | Meget ofte (80–99 %) | I 1 tilstand |
| ITGB4integrin subunit beta 4 | Meget ofte (80–99 %) | I 1 tilstand |
| KLRC4killer cell lectin like receptor C4 | Meget ofte (80–99 %) | I 1 tilstand |
| LIPAlipase A, lysosomal acid type | Meget ofte (80–99 %) | I 2 tilstande |
| LMOD1leiomodin 1 | Meget ofte (80–99 %) | I 1 tilstand |
| MALT1MALT1 paracaspase | Meget ofte (80–99 %) | I 1 tilstand |
| MEFVMEFV innate immunity regulator, pyrin | Meget ofte (80–99 %) | I 2 tilstande |
| MMUTmethylmalonyl-CoA mutase | Meget ofte (80–99 %) | I 2 tilstande |
| MYH11myosin heavy chain 11 | Meget ofte (80–99 %) | I 1 tilstand |
| MYLKmyosin light chain kinase | Meget ofte (80–99 %) | I 1 tilstand |
Vis 113 gener mere
| Gen | Hvor ofte det ses | Tilstande |
|---|---|---|
| NLRP3NLR family pyrin domain containing 3 | Meget ofte (80–99 %) | I 2 tilstande |
| NRTNneurturin | Meget ofte (80–99 %) | I 1 tilstand |
| PTENphosphatase and tensin homolog | Meget ofte (80–99 %) | I 1 tilstand |
| RETret proto-oncogene | Meget ofte (80–99 %) | I 1 tilstand |
| RHBDF2rhomboid 5 homolog 2 | Meget ofte (80–99 %) | I 1 tilstand |
| SDHAsuccinate dehydrogenase complex flavoprotein subunit A | Meget ofte (80–99 %) | I 2 tilstande |
| SDHBsuccinate dehydrogenase complex iron sulfur subunit B | Meget ofte (80–99 %) | I 2 tilstande |
| SDHCsuccinate dehydrogenase complex subunit C | Meget ofte (80–99 %) | I 2 tilstande |
| SEMA3Csemaphorin 3C | Meget ofte (80–99 %) | I 1 tilstand |
| SEMA3Dsemaphorin 3D | Meget ofte (80–99 %) | I 1 tilstand |
| SLC1A3solute carrier family 1 member 3 | Meget ofte (80–99 %) | I 1 tilstand |
| SLC46A1solute carrier family 46 member 1 | Meget ofte (80–99 %) | I 1 tilstand |
| SMARCB1SWI/SNF related BAF chromatin remodeling complex subunit B1 | Meget ofte (80–99 %) | I 2 tilstande |
| SMOsmoothened, frizzled class receptor | Meget ofte (80–99 %) | I 2 tilstande |
| SREBF1sterol regulatory element binding transcription factor 1 | Meget ofte (80–99 %) | I 1 tilstand |
| STAT4signal transducer and activator of transcription 4 | Meget ofte (80–99 %) | I 1 tilstand |
| TLR4toll like receptor 4 | Meget ofte (80–99 %) | I 1 tilstand |
| UBAC2UBA domain containing 2 | Meget ofte (80–99 %) | I 1 tilstand |
| AIPAHR interacting HSP90 co-chaperone | Ofte (30–79 %) | I 1 tilstand |
| AKT1AKT serine/threonine kinase 1 | Ofte (30–79 %) | I 1 tilstand |
| AQP2aquaporin 2 | Ofte (30–79 %) | I 1 tilstand |
| ATMATM serine/threonine kinase | Ofte (30–79 %) | I 1 tilstand |
| ATRXATRX chromatin remodeler | Ofte (30–79 %) | I 2 tilstande |
| AVPR2arginine vasopressin receptor 2 | Ofte (30–79 %) | I 1 tilstand |
| BAP1BRCA1 associated deubiquitinase 1 | Ofte (30–79 %) | I 1 tilstand |
| BAZ1Bbromodomain adjacent to zinc finger domain 1B | Ofte (30–79 %) | I 1 tilstand |
| BMPR1Abone morphogenetic protein receptor type 1A | Ofte (30–79 %) | I 1 tilstand |
| BRAFB-Raf proto-oncogene, serine/threonine kinase | Ofte (30–79 %) | I 1 tilstand |
| BRCA2BRCA2 DNA repair associated | Ofte (30–79 %) | I 2 tilstande |
| BUD23BUD23 rRNA methyltransferase and ribosome maturation factor | Ofte (30–79 %) | I 1 tilstand |
| CACNA1Acalcium voltage-gated channel subunit alpha1 A | Ofte (30–79 %) | I 2 tilstande |
| CAV1caveolin 1 | Ofte (30–79 %) | I 2 tilstande |
| CCN2cellular communication network factor 2 | Ofte (30–79 %) | I 2 tilstande |
| CCR6C-C motif chemokine receptor 6 | Ofte (30–79 %) | I 2 tilstande |
| CDH23cadherin related 23 | Ofte (30–79 %) | I 2 tilstande |
| CHEK2checkpoint kinase 2 | Ofte (30–79 %) | I 1 tilstand |
| CLIP2CAP-Gly domain containing linker protein 2 | Ofte (30–79 %) | I 1 tilstand |
| CTLA4cytotoxic T-lymphocyte associated protein 4 | Ofte (30–79 %) | I 1 tilstand |
| CTNNB1catenin beta 1 | Ofte (30–79 %) | I 1 tilstand |
| DLEC1DLEC1 cilia and flagella associated protein | Ofte (30–79 %) | I 1 tilstand |
| DNAJC30DnaJ heat shock protein family (Hsp40) member C30 | Ofte (30–79 %) | I 1 tilstand |
| DNASE1L3deoxyribonuclease 1L3 | Ofte (30–79 %) | I 1 tilstand |
| EIF4Heukaryotic translation initiation factor 4H | Ofte (30–79 %) | I 1 tilstand |
| ELNelastin | Ofte (30–79 %) | I 1 tilstand |
| EPCAMepithelial cell adhesion molecule | Ofte (30–79 %) | I 1 tilstand |
| EWSR1EWS RNA binding protein 1 | Ofte (30–79 %) | I 1 tilstand |
| FKBP6FKBP prolyl isomerase family member 6 (inactive) | Ofte (30–79 %) | I 1 tilstand |
| GATA2GATA binding protein 2 | Ofte (30–79 %) | I 1 tilstand |
| GLAgalactosidase alpha | Ofte (30–79 %) | I 1 tilstand |
| GTF2Igeneral transcription factor IIi | Ofte (30–79 %) | I 1 tilstand |
| GTF2IRD1GTF2I repeat domain containing 1 | Ofte (30–79 %) | I 1 tilstand |
| GTF2IRD2GTF2I repeat domain containing 2 | Ofte (30–79 %) | I 1 tilstand |
| HLA-DPA1major histocompatibility complex, class II, DP alpha 1 | Ofte (30–79 %) | I 1 tilstand |
| HLA-DPB1major histocompatibility complex, class II, DP beta 1 | Ofte (30–79 %) | I 1 tilstand |
| HLA-DRB1major histocompatibility complex, class II, DR beta 1 | Ofte (30–79 %) | I 2 tilstande |
| HMBShydroxymethylbilane synthase | Ofte (30–79 %) | I 1 tilstand |
| IRF5interferon regulatory factor 5 | Ofte (30–79 %) | I 2 tilstande |
| KIAA0319LKIAA0319 like | Ofte (30–79 %) | I 1 tilstand |
| KITKIT proto-oncogene, receptor tyrosine kinase | Ofte (30–79 %) | I 1 tilstand |
| KRASKRas proto-oncogene, GTPase | Ofte (30–79 %) | I 2 tilstande |
| LIMK1LIM domain kinase 1 | Ofte (30–79 %) | I 1 tilstand |
| MEN1menin 1 | Ofte (30–79 %) | I 1 tilstand |
| METTL27methyltransferase like 27 | Ofte (30–79 %) | I 1 tilstand |
| MLH1mutL homolog 1 | Ofte (30–79 %) | I 1 tilstand |
| MSH2mutS homolog 2 | Ofte (30–79 %) | I 1 tilstand |
| MSH6mutS homolog 6 | Ofte (30–79 %) | I 1 tilstand |
| MUTYHmutY DNA glycosylase | Ofte (30–79 %) | I 1 tilstand |
| NCF1neutrophil cytosolic factor 1 | Ofte (30–79 %) | I 1 tilstand |
| NF2NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor | Ofte (30–79 %) | I 1 tilstand |
| NPATnuclear protein, coactivator of histone transcription | Ofte (30–79 %) | I 1 tilstand |
| PDGFBplatelet derived growth factor subunit B | Ofte (30–79 %) | I 1 tilstand |
| PDGFRAplatelet derived growth factor receptor alpha | Ofte (30–79 %) | I 1 tilstand |
| PIK3CAphosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | Ofte (30–79 %) | I 2 tilstande |
| PMS1PMS1 homolog 1, mismatch repair system component | Ofte (30–79 %) | I 1 tilstand |
| PMS2PMS1 homolog 2, mismatch repair system component | Ofte (30–79 %) | I 1 tilstand |
| POLD1DNA polymerase delta 1, catalytic subunit | Ofte (30–79 %) | I 1 tilstand |
| POLEDNA polymerase epsilon, catalytic subunit | Ofte (30–79 %) | I 1 tilstand |
| PRTN3proteinase 3 | Ofte (30–79 %) | I 1 tilstand |
| PTPN22protein tyrosine phosphatase non-receptor type 22 | Ofte (30–79 %) | I 1 tilstand |
| RFC2replication factor C subunit 2 | Ofte (30–79 %) | I 1 tilstand |
| RNF6ring finger protein 6 | Ofte (30–79 %) | I 1 tilstand |
| RPS20ribosomal protein S20 | Ofte (30–79 %) | I 1 tilstand |
| SEMA4Asemaphorin 4A | Ofte (30–79 %) | I 1 tilstand |
| SMARCE1SWI/SNF related BAF chromatin remodeling complex subunit E1 | Ofte (30–79 %) | I 1 tilstand |
| STX1Asyntaxin 1A | Ofte (30–79 %) | I 1 tilstand |
| SUFUSUFU negative regulator of hedgehog signaling | Ofte (30–79 %) | I 1 tilstand |
| TBK1TANK binding kinase 1 | Ofte (30–79 %) | I 1 tilstand |
| TBL2transducin beta like 2 | Ofte (30–79 %) | I 1 tilstand |
| TERTtelomerase reverse transcriptase | Ofte (30–79 %) | I 1 tilstand |
| TGFBR2transforming growth factor beta receptor 2 | Ofte (30–79 %) | I 2 tilstande |
| TICAM1TIR domain containing adaptor molecule 1 | Ofte (30–79 %) | I 1 tilstand |
| TLR3toll like receptor 3 | Ofte (30–79 %) | I 1 tilstand |
| TMEM270transmembrane protein 270 | Ofte (30–79 %) | I 1 tilstand |
| TRAF3TNF receptor associated factor 3 | Ofte (30–79 %) | I 1 tilstand |
| TRAF7TNF receptor associated factor 7 | Ofte (30–79 %) | I 1 tilstand |
| TRMT5tRNA methyltransferase 5 | Ofte (30–79 %) | I 1 tilstand |
| UNC93B1unc-93B1 regulator of TLR signaling | Ofte (30–79 %) | I 1 tilstand |
| VPS37DVPS37D subunit of ESCRT-I | Ofte (30–79 %) | I 1 tilstand |
| WT1WT1 transcription factor | Ofte (30–79 %) | I 1 tilstand |
| WWOXWW domain containing oxidoreductase | Ofte (30–79 %) | I 1 tilstand |
| CDC73cell division cycle 73 | Nogle gange (5–29 %) | I 2 tilstande |
| CDKN2Acyclin dependent kinase inhibitor 2A | Nogle gange (5–29 %) | I 1 tilstand |
| CLCNKBchloride voltage-gated channel Kb | Nogle gange (5–29 %) | I 1 tilstand |
| FLI1Fli-1 proto-oncogene, ETS transcription factor | Nogle gange (5–29 %) | I 1 tilstand |
| MYCMYC proto-oncogene, bHLH transcription factor | Nogle gange (5–29 %) | I 1 tilstand |
| PALB2partner and localizer of BRCA2 | Nogle gange (5–29 %) | I 1 tilstand |
| PALLDpalladin, cytoskeletal associated protein | Nogle gange (5–29 %) | I 1 tilstand |
| RAB27ARAB27A, member RAS oncogene family | Nogle gange (5–29 %) | I 1 tilstand |
| RABL3RAB, member of RAS oncogene family like 3 | Nogle gange (5–29 %) | I 1 tilstand |
| SDHDsuccinate dehydrogenase complex subunit D | Nogle gange (5–29 %) | I 1 tilstand |
| SLC12A3solute carrier family 12 member 3 | Nogle gange (5–29 %) | I 1 tilstand |
| SMAD4SMAD family member 4 | Nogle gange (5–29 %) | I 1 tilstand |
| TP53tumor protein p53 | Nogle gange (5–29 %) | I 1 tilstand |
Hvor hyppigt det ses hos personer med en af genets tilstande, den hyppigste værdi på tværs af dem, sådan som Human Phenotype Ontology registrerer det. Disse sider beskriver egenskaber og den forskning, der ligger bag dem. De er ikke en diagnose, og hvis du har spørgsmål om symptomer, bør du spørge en læge eller genetisk rådgiver.
Snævrere træk
Bredere træk
Hvor oplysningerne kommer fra
- Human Phenotype Ontology, udgivelse 2026-09-01: egenskaben, dens navne, definition og de gener, der er knyttet til den. Læs mere på hpo.jax.org.
- Dataudgivelse 2026.10.16-c6eea6bf.
Én test. Svar for hele livet.
Fra 449 $Gratis forsendelse · Resultater på 6–8 uger